Modell AE, Lim D, Nguyen TM, Sreekanth V, Choudhary A. CRISPR-based therapeutics: current challenges and future applications. Trends in pharmacological sciences. 2022;43(2):151-161. doi:10.1016/j.tips.2021.10.012
Chemical Biology and Therapeutics Science Program
Siegenfeld AP, Roseman S, Roh H, et al. Polycomb-lamina antagonism partitions heterochromatin at the nuclear periphery. Nature communications. 2022;13(1):4199. doi:10.1038/s41467-022-31857-5
Ngan K. CRISPR-Suppressor Scanning for Systematic Discovery of Drug-Resistance Mutations. Current protocols. 2022;2(12):e614. doi:10.1002/cpz1.614
Gosavi P, Ngan K, Yeo M, et al. Profiling the Landscape of Drug Resistance Mutations in Neosubstrates to Molecular Glue Degraders. ACS central science. 2022;8(4):417-429. doi:10.1021/acscentsci.1c01603
Chen PJ, Hussmann JA, Yan J, et al. Enhanced prime editing systems by manipulating cellular determinants of editing outcomes. Cell. 2021;184(22):5635-5652.e29. doi:10.1016/j.cell.2021.09.018
Clemons PA, Bittker JA, Wagner FF, et al. The Use of Informer Sets in Screening: Perspectives on an Efficient Strategy to Identify New Probes. SLAS Discov. 2021;26(7):855-861. doi:10.1177/24725552211019410
Modell AE, Lai S, Nguyen TM, Choudhary A. Bifunctional modalities for repurposing protein function. Cell chemical biology. 2021;28(7):1081-1089. doi:10.1016/j.chembiol.2021.06.005
Kahraman S, Manna D, Dirice E, et al. Harnessing reaction-based probes to preferentially target pancreatic β-cells and β-like cells. Life science alliance. 2021;4(4). doi:10.26508/lsa.202000840
Modell AE, Siriwardena SU, Shoba VM, Li X, Choudhary A. Chemical and optical control of CRISPR-associated nucleases. Current opinion in chemical biology. 2021;60:113-121. doi:10.1016/j.cbpa.2020.10.003
Morrison MS, Wang T, Raguram A, Hemez C, Liu DR. Disulfide-compatible phage-assisted continuous evolution in the periplasmic space. Nature communications. 2021;12(1):5959. doi:10.1038/s41467-021-26279-8